Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.

Autor: Marciscano AE; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: marcisca@mskcc.org., Haimovitz-Friedman A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Lee P; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California., Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland., Tomé WA; Department of Radiation Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York., Guha C; Department of Radiation Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York., Spring Kong FM; Radiation Oncology Program at University Hospitals Seidman Cancer Center, Cleveland, Ohio., Sahgal A; Department of Radiation Oncology, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Ontario, Canada., El Naqa I; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan., Rimner A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Marks LB; Department of Radiation Oncology and The Linberger Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Formenti SC; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York., DeWeese TL; Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jazyk: angličtina
Zdroj: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 May 01; Vol. 110 (1), pp. 35-52. Date of Electronic Publication: 2019 Mar 02.
DOI: 10.1016/j.ijrobp.2019.02.046
Databáze: MEDLINE